Avanti Biosciences is a biotechnology company that provides therapies for patients with debilitating diseases. It aims to develop a form of therapy designed to control complex diseases via new chemical entities (NCE) derived from natural products. The company focuses on such therapeutic areas as Down syndrome, hyperinsulinemia, Alzheimer's disease, and multiple sclerosis.